SNCA and synucleinopathy: Overall, our initial characterization of an exceptionally large PARK4 pedigree from Turkey provided insights into the prodromal stage of monogenic synucleinopathy, defining a molecular signature in the blood transcriptome that might be relevant for predictive diagnostics in groups of at-risk individuals.